发明授权
US5951982A Methods to suppress an immune response with variant CD44-specific
antibodies
失效
用变体CD44特异性抗体抑制免疫应答的方法
- 专利标题： Methods to suppress an immune response with variant CD44-specific antibodies
- 专利标题（中）： 用变体CD44特异性抗体抑制免疫应答的方法
-
申请号： US359850申请日： 1994-12-20
-
公开(公告)号： US5951982A公开(公告)日： 1999-09-14
- 发明人: Margot Zoller , Peter Herrlich , Helmut Ponta
- 申请人： Margot Zoller , Peter Herrlich , Helmut Ponta
- 申请人地址： CT Ridgefield
- 专利权人： Boehringer Ingelheim Pharmaceuticals, Inc.
- 当前专利权人： Boehringer Ingelheim Pharmaceuticals, Inc.
- 当前专利权人地址： CT Ridgefield
- 优先权： DEX4134982 19911023
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K38/00 ; A61P17/00 ; A61P29/00 ; A61P37/00 ; A61P37/06 ; A61P37/08 ; C07K16/28 ; C12P21/08 ; G01N33/577
摘要：
The present invention relates to a method of reducing or suppressing an immune response with antibodies specific for variants of the glycoprotein CD44. The invention further relates to a method of preventing or treating an immunoregulatory disorder or disease with these antibodies.
信息查询
